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Background: Toll-like receptors (TLRs) are recognized as important contributors to the initiation and modulation of
the inflammatory response in the eye. This study investigated the precise expression patterns and functionality of
TLRs in human corneal epithelial cells (HCE) and in conjunctival fibroblasts (HCF).
Methods: The cell surface expression of TLRs 2-4, TLR7 and TLR9 in HCE and HCF was examined by flow cytometry
with or without stimulation with lipopolysaccharide (LPS) or polyinosinic:polycytidylic acid (poly I:C). The mRNA
expression of the TLRs was determined by real-time PCR. The protein content levels of interleukin (IL)-6, IL-8, IL-1β
and tumor necrosis factor-α (TNF-α) were measured in HCE and HCF using multiplex fluorescent bead
immunoassay (FBI).
Results: The surface expression of TLR3 and TLR4 was detected on both HCE and HCF. Following incubation with
LPS, the percentage of HCE cells staining for TLR4 decreased from 10.18% to 0.62% (P < 0.001). Incubation with poly
I:C lowered the percentage of HCE cells positive for TLR3 from 10.44% to 2.84% (P < 0.001). The mRNA expression of
TLRs2, 4, 7 and 9 was detected in HCE only. Activation of HCE with LPS complex elicited protein secretion up to
4.51 ± 0.85-fold higher levels of IL-6 (P < 0.05), 2.5 ± 0.36-fold IL-8 (P > 0.05), 4.35 ± 1.12-fold IL-1β (P > 0.05) and
29.35 ± 2.3-fold TNFα (P < 0.05) compared to cells incubated in medium.
Conclusions: HCF and HCE both express TLRs that respond to specific ligands by increasing cytokine expression.
Following activation, the surface expression of TLR3 and TLR4 on HCE is decreased, thus creating a negative
feedback loop, mitigating the effect of TLR activation.
Keywords: Toll-like receptor, Corneal epithelial, Conjunctival fibroblasts, Lipopolysaccharide, Polyinosinic:
polycytidylic acid, Culture cellsBackground
The ocular surface consists of the eyelid, cornea, con-
junctiva, lacrimal gland and tear film, and provides the
first line of defense against mechanical and biological in-
sults [1]. The corneal epithelium, in particular, serves a
critical function of the mucosal innate immune system,
as it is constantly exposed to microorganisms and their
virulent products [2]. An important characteristic of the* Correspondence: dr.avi.solomon@gmail.com
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reproduction in any medium, provided the orcorneal epithelial cell function is the ability to recognize a
wide range of pathogens, and upon challenge to secrete
cytokines and other immune mediators, thereby initiating
an efficient, highly sensitive, immune response [3].
Microorganisms possess highly conserved motifs and
pathogen associated molecular patterns (PAMP) that are
recognized by pattern recognition receptors (PRR) found
on cells of the innate immune system. Toll-like receptors
(TLR) are a family of PRR, capable of recognizing and
responding to various PAMP. Upon stimulation of the
receptor, a cascade of intracellular signaling is initiated,
culminating in the activation of NF-κB and secretion of
a variety of cytokines, chemokines and expression of co-l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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TLRs were demonstrated in humans, each presents a
tendency towards a specific PAMP. For example, TLR4
recognizes lipopolysaccharide (LPS), the endotoxin of
Gram-negative bacteria, while TLR3 is a sensor of viral
dsRNA [4].
A widespread expression of various TLRs has been
demonstrated in the human eye, including the retina,
uvea, lacrimal gland and conjunctiva [5,6]. TLRs are also
found in the human cornea, and have been implicated in
several infectious diseases [7]. Despite the importance of
the TLR family, the exact localization in the human cor-
nea of its various members and their ability to respond
to antigenic stimuli is yet to be fully understood. More-
over, there are discrepancies in the literature regarding
the characterization of TLR3 and TLR4 in HCE cells.
Like HCE cells, conjunctival fibroblasts have long been
implicated in the pathophysiology of several chronic dis-
orders of the ocular surface such as ocular cicatricial
pemphigoid (OCP), dry eye, pterygium and vernal kerato-
conjunctivitis [6-8]. Unlike HCE cells that have been thor-
oughly investigated, this cell population did not receive
similar attention. We believe that characterizing the TLR
family in these cells might help future research to eluci-
date the nature of some diseases of the ocular surface.
In the present study, we present the results of a sys-
tematic approach to the characterization of TLR3 and
TLR4 in primary HCE and HCF.
Methods
The Hadassah Medical Center Institutional Review Board
(IRB) approval was obtained for this study (IRB protocol
number and version: EFA-EFE-IV-01). This study followed
the tenets of the Declaration of Helsinki.
Human corneal epithelial (HCE) cells
HCE cells were cultured from human corneoscleral rim
explants, taken from several different human donors,
provided by the Department of Ophthalmology at the
Hadassah Medical Center, using a previously described
method [9].
HCE cells were cultured in supplemented hormonal
epithelial medium (SHEM) [10] and were incubated at
37°C under 95% humidity and 5% CO2. The culture
medium was replaced every other day. Cultures were
kept for 10 to 14 days until a density of 90% confluence
was observed.
Human conjunctival fibroblasts (HCF)
Human conjunctiva explant cultures were established
using specimens obtained at the time of strabismus sur-
gery and were used for the isolation and culture within
1–3 hours after surgery. HCF were cultured as previ-
ously described [11]. In brief, HCF were cultured insupplemented fibroblasts medium which contained Dul-
becco’s modified Eagle medium (DMEM) with nutrient
mixture F12 (Gibco), supplemented with 4 mM glutamine,
10% fetal calf serum (FCS), 100 U of penicillin and 100 μg
of streptomycin per ml. The HCF were incubated at 37°C
under 95% humidity and 5% CO2. The medium was re-
placed every 2–3 days. Cultures were kept for 10 to 14 days
until a density of 90% confluence was observed.
Human neuron-committed teratocarcinoma (NT2) cells
Human neuron-committed teratocarcinoma (NT2) cells
line do not express TLRs and thus served as negative
control for the flow cytometry and PCR analysis. NT2
cells line was grown in DMEM with nutrient mixture
F12 (Gibco), supplemented with 4 mM glutamine, 10%
fetal calf serum (FCS), 100 U of penicillin and 100 μg of
streptomycin per ml. Briefly, 106 NT2 cells were seeded
into 75-cm2 flasks with 5 ml of medium.
Human peripheral blood mononuclear (HPBM) cells
Mononuclear cells are known to express various TLRs,
and thus served as positive control for the flow cytometry
and PCR analysis. The cells were separated from outdated
venous blood samples obtained from the Hadassah
Medical Center Blood Bank. Blood samples were placed
in 50 ml polypropylene tubes and mixed with equal
volumes of PBS. Ficoll-Hypaque solution (Sigma Chemical
Co. St. Louis) was slowly layered under the blood/PBS
mixture. Afterwards, the 50 ml tube was centrifuged
30 min at 2000 rpm (900 g) with no brake. The mono-
nuclear cell layer was aspirated using a sterile pipette and
transferred into a second centrifuge tube.
Monoclonal antibodies
Anti-human monoclonal antibody to TLR3 (TLR3.7)
was purchased from Hycult Biotech and anti-human
monoclonal antibody to TLR4 (HTA125) was purchased
from NOVUS Biologicals. FITC-conjugated AffiniPure
donkey anti-mouse IgG (H + L) antibody and AffiniPure
F(ab’)2 fragment donkey anti-human IgG (H + L) were
purchased from Jackson ImmunoResearch Laboratories.
Purified anti-mouse IgG1 isotype control was purchased
from BioLegend.
TLR3 and TLR4 expression in HCE cells - by flow
cytometry
The cells were either incubated with TLR-specific anti-
bodies or with isotype-matched control antibodies. We
also used NT2 cells as a negative control and HPBM
cells as a positive control.For flow cytometry analysis we
used anti-human monoclonal antibodies to human TLR3
(TLR3.7) (Hycult Biotech) and TLR4 (HTA125) (NOVUS
Biologicals). HCE cells were washed twice in FACS buffer
(Dulbecco’s PBS containing 0.5% BSA and 0.1% sodium
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bodies (1 μg) together with human IgG (10 μg) for 30 min
at 4°C. After the cells were washed twice with the above
buffer, FITC-labeled secondary antibody was added and
further incubated for 30 min at 4°C. The cells were then
analyzed on a FACScan (BD Biosciences). For isotype con-
trol, the primary antibodies used were anti-mouse IgG1 or
anti-mouse IgG2a.
For intracellular staining of TLR3 and TLR4, the cells
were fixed in 1% formaldehyde and permeabilized using
0.1% saponin [12]. The cells were subsequently incubated
with monoclonal antibodies and FITC-secondary anti-
bodies, as described above. The antibodies were diluted
using a 0.1% saponin-containing PBS solution.
Expression of TLRs-specific mRNA in HCE cells by
real-time PCR
Quantitative real-time reverse transcriptase polymerase
chain reaction (RT-PCR) was conducted in triplicates in
a final volume of 15 μL. The reaction containing 2×
power SYBR green PCR Master Mix (Applied Biosystems,
Warrington, UK), cDNA together with forward and re-
verse primer of TLRs 2–4, TLR7 and TLR9 (Table 1). The
primers were selected with an AB Primer Express pro-
gram (v.2.0, Applied Biosystems, USA) and synthesized
(Syntezza, Israel). Amplification was performed using the
ABI PRISM® 7000 sequence detector (Applied Biosystems,
USA).
HCE and HCF activation
For TLR activation, HCE and HCF cells were incubated
for 4 hours with either LPS 1 μg/ml supplemented with
500 ng/ml Cluster of differentiation 14 (CD14) and
500 ng/ml Lipopolysaccharide binding protein (LBP), to-














Antisense 3′-CATATCCTACAACAAACTTGTCTGGAA-5′[13,14] or with Poly I:C at a dose of 25 μg/ml [15]. For
maximal induction of IL-6 and IL-8, the stimulus expos-
ure time lasted 4 hours for protein content measurement
and 3 hours for mRNA expression level measurement. For
TNF-α and IL-1β the stimulus lasted 15 hours for protein
content measurement, and 12 hours for mRNA expres-
sion level measurements.
Cytokines protein secretion after stimulation of HCE and
HCF with LPS and poly I:C - by a multiplex fluorescent
bead immunoassay (FBI)
The cytokines protein concentration levels were mea-
sured using a multiplex fluorescent bead immunoassay
(CBA, Human Inflammatory Cytokines Kit, BD Biosciences,
USA). The test was performed and analyzed according to
the manufacturer’s instructions and was performed as de-
scribed previously [16].
Cytokines mRNA expression in response to activation
of HCE and HCF with LPS and poly I:C - by real-time
polymerase chain reaction
Total RNA was extracted from the cells samples with
RNAqueous Kit (Ambion, Austin, TX, USA) following
the manufacturer’s instructions. cDNA was synthesized
from purified and concentrated 0.5 μg RNA from each
sample using a High Capacity cDNA Reverse Transcrip-
tion Kit (Applied Biosystems, ABI, USA).
Real-time polymerase chain reaction (PCR) was per-
formed using TaqMan® Gene Expression Assays (Applied
Biosystems, Foster City, CA, USA) in the ABI Prism
7900HT Sequence Detection System (Applied Biosystems,
Foster City, CA, USA) as described previously (18). Nega-
tive controls were included to evaluate DNA contamin-
ation of isolated RNA and reagents. The fold changes
of the gene expression in the samples were normal-
ized to the endogenous gene hypoxanthine phosphoribo-
syltransferase 1 (HPRT1; Applied Biosystems, Foster City,
CA, USA).
Statistical analysis
All tests were carried out on four independent cell cul-
tures, and performed in triplicates for each of the treat-
ments. Statistical analysis and multiple comparisons were
performed by one-way ANOVA using the InStat software
version 3.0 (InStat software Inc., USA).
Results
HCE cells express TLR3 and TLR4 on the cell surface
Our aim was to determine whether HCE cells express
TLR3 and TLR4 on their cell surface. Flow cytometry ana-
lysis of HCE cells using specific antibodies to TLR3 and
TLR4 is presented in Figure 1. As shown, TLR3 (13.15 ±
3.43%; P < 0.01) as well as TLR4 (7.85 ± 4.32%; P < 0.05)
were present on the cell surface of HCE cells and as

























Figure 1 HCE, HCF and HPBM cells expression of TLR3 and TLR4 on the cell surface, examined by flow cytometry. NT2 cells served as a
negative control. Cells were immunostained with TLR3-specific antibody, TLR4-specific antibody or isotype control antibody. Data shown
(mean ± SD) are representative of four independent experiments. The single asterisk (p < 0.05), the double asterisks (p < 0.01) and the three
asterisks (p < 0.001) represents statistical significance for experiments. TLR: Toll-like receptors, ISO: Isotype-control, NT2: Neuron-committed
teratocarcinoma, HPBM: Human peripheral blood mononuclear, HCE: Human corneal epithelial cells.
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as well showing TLR4 on the cell surface (33.68 ± 0.15%;
P < 0.001). In these cells TLR3 staining was positive only
when cells were initially permeabilized with 0.1% saponin
(97.74 ± 1.98%; P < 0.001).
HCF cells express TLR3 and TLR4 on the cell surface
We found that both TLR3 and TLR4 were present on
the cell surface of HCF cells (Figure 1) using flow cy-
tometry analysis. As compared to isotype control, we
found significant staining both for TLR3 (12.23 ±
2.36%; P < 0.001) and TLR4 (7.95 ± 0.7%; P < 0.001).
The same controls were used as in the experiments
with HCE cells, NT2 cells were minorly stained
(0.09 ± 003; P > 00.5), HPBM cells were stained for
TLR4 (33.68 ± 0.15%; P < 0.001) and for TLR3 (97.74 ±
1.98%; P < 0.001, Figure 1).
HCE cells express TLR-specific mRNA
Real-time PCR results showed that specific mRNAs en-
coding for TLR2, TLR4, TLR7 and TLR9 were present
in HCE cells. The mRNA expression of TLR2 was
3.92 ± 0.82 (P < 0.01) fold; TLR4 3.89 ± 0.34 (P < 0.01)
fold; TLR7 3.76 ± 0.44 (P < 0.01) fold and TLR9 2.84 ± 0.63
(P < 0.01) fold compared to HPRT1 mRNA expression
(Figure 2).
We have also shown the expression of these receptors
in HPBM cells. The mRNA expression in HPBM cells
of TLR2 was 3.1 ± 0.48 (P < 0.01) fold; TLR4 6.17 ± 0.86
(P < 0.01) fold and TLR9 4.61 ± 0.51 (P < 0.01) fold
(Figure 2) and TLR 3 and TLR 7 were not expressed
in HPBM cells. In NT2 none of these receptors was
expressed (Figure 2).TLR3 and TLR4 surface expression decreases following
activation in HCE cells
After determining that HCE express both TLR3- and
TLR4-specific mRNA and express the receptors on the
cell surface, we investigated whether stimulation by their
respective ligands might affect the level of surface expres-
sion. For activation we used poly I:C, the ligand of TLR3,
and LPS, the ligand of TLR4. Incubation with poly I:C
(25 μg/ml) for 4 hours decreased the percentage of HCE
cells staining positive for TLR3 from 11.84 ± 1.77% to
3.04 ± 2.37% (P < 0.05, Figure 3A). Following incubation
with LPS (1 μg/ml) for 4 hours the percentage of HCE
cells staining positive for TLR4 decreased from 17.31 ±
1.88% to 4.79 ± 2.37% (P < 0.05, Figure 3B).
HCF cells were likewise treated with either poly I:C or
LPS, and the surface expression of TLR3 and TLR4, re-
spectively, was evaluated using flow cytometry. Follow-
ing stimulation using poly I:C, the surface staining of
TLR3 decreased from 9.07% to 7.29% (P > 0.05). TLR4
activation using LPS resulted in decreased surface stain-
ing from 4.58% to 3.99% (P > 0.05). Hence, HCF stimula-
tion using TLR-specific ligands did not result in a
significant decrease in surface staining of the respective
receptors.
TLR3 and TLR4-specific mRNA levels are affected by
receptor stimulation
HCE cells activation with poly I:C (Figure 4A) elicited
an increase up to 6.49 ± 1.1 in the content of TLR3-
specific mRNA in comparison to medium (P < 0.05). As
expected, exposure of HCE cells to LPS did not elicit a
statistically significant increase in TLR3-specific mRNA





























Figure 2 Expression of TLRs-specific mRNA in HCE cells. The mRNA expression of TLR 2–4, TLR7 and TLR9 was examined by Real-time PCR.
TLRs 2–4, TLR7 and TLR9 mRNA expression in HCE cells is shown relative to HPRT1. Data derived from three independent experiments and shown
as mean ± SD. The single asterisk (p < 0.05) represent statistical significance for experiments. TLR: Toll-like receptors, NT2: Neuron-committed
teratocarcinoma, HPBM: Human peripheral blood mononuclear, HCE: Human corneal epithelium.
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TLR4-specific mRNA in comparison to medium (P < 0.05).
Interestingly, HCE cells exposure to poly I:C elicited an in-
crease in TLR4-specific mRNA which was statistically sig-
nificant (P < 0.05; Figure 4B).
Cytokines protein secretion in response to activation of
HCE cells with LPS and poly I:C
Incubation of HCE cells with LPS complex (Figure 5A)
and Poly I:C (Figure 6A) elicited higher levels of cyto-
kines compared to cells incubated in medium alone.
Data from multiplex FBI demonstrated that the incu-
bation of HCE cells with the LPS-alone elicited up to
2.8 ± 0.55-fold higher levels of IL-6 (P < 0.05), 1.5 ± 0.21-A B
Figure 3 TLR3 and TLR4 surface expression in HCE and HCF cells decr
TLR3 surface expression in naïve, HCE and HCF cells following activation us
following activation using LPS (B). Data derived from three independent ex
statistical significance following activation. TLR: Toll-like receptors, HCE: Hum
polyinosinic:polycytidylic acid.fold IL-8 (P > 0.05), 2.35 ± 0.46-fold IL-1β (P < 0.05) and
5.8 ± 1.3-fold TNFα (P < 0.01) compared to cells incu-
bated in medium alone (Figure 5A). LPS stimulation
combined with CD14 and LBP (LPS complex) increased
cytokines production in HCE cells in relation to incuba-
tion with LPS alone in cell culture. The incubation of
HCE with the LPS complex elicited up to 4.51 ± 0.85-
fold higher levels of IL-6 (P < 0.05), 2.5 ± 0.36-fold IL-8
(P < 0.05), 4.35 ± 1.12-fold IL-1β (P < 0.05) and 29.35 ±
2.3-fold TNFα (P < 0.01) compared to cells incubated in
medium alone (Figure 5A).
Incubation of HCE cells with the poly I:C elicited up
to 34.31 ± 4.2-fold higher levels of IL-6 (P < 0.001), 4 ±
0.5-fold IL-8 (P < 0.05), 14.68 ± 1.65-fold IL-1β (P < 0.01)eases following activation using poly I:C or LPS, respectively.
ing poly I:C (A). TLR4 surface expression in naïve, HCE and HCF cells
periments and shown as mean ± SD. The asterisk (p < 0.05) represent





























































Figure 4 TLR3 and TLR4-specific mRNA levels are affected by receptor stimulation. Relative expression of TLR3-specific mRNA in naïve cells,
and in cells treated with poly I:C in comparison to medium (A). Relative expression of TLR4-specific mRNA in naïve cells and in cells treated with
LPS in comparison to medium (B). Data derived from four independent experiments. The asterisk (p < 0.05) represent statistical significance for
experiments. All values are expressed as mean ± SD. TLR: Toll-like receptors, Human peripheral blood mononuclear, HCE: Human corneal
epithelium, LPS: Lipopolysaccharide, Poly I:C: polyinosinic:polycytidylic acid.
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incubated in medium alone (Figure 6A).
Cytokines mRNA expression in response to activation of
HCE cells with LPS and poly I:C
The mRNA expression levels of IL-6, IL-1β, TNF-α and
IL-8 were significantly increased in HCE cells upon
stimulation with LPS complex (Figure 5B) and Poly I:C
(Figure 6A) compared to non-stimulated cells.
Stimulation with LPS complex induced a significant ele-
vation of the mRNA expression levels of IL-6 to 4.15 ±
0.52 fold (P < 0.05), IL-8 to 5.2 ± 0.6-fold (P < 0.05), IL-1β
to 6.1 ± 0.45 fold (P < 0.01) and TNFα to 4.61 ± 0.8 fold
(P < 0.05) compared to cells incubated in medium alone
(Figure 5B).
Poly I:C stimulation induced a significant elevation of
the mRNA expression levels of IL-6 to 45.41 ± 6.1fold
(P < 0.001), IL-8 to 11.79 ± 2.05 fold (P < 0.05), IL-1β
to 23.81 ± 3.8 fold (P < 0.001) and TNFα to 68.8 ± 7.9fold (P < 0.001) compared to cells incubated in medium
alone (Figure 6A).
Cytokines protein secretion in response to activation of
HCF with LPS and poly I:C
We found that LPS stimulation elicited both higher pro-
tein and mRNA contents of IL-6 and IL-8, as compared
to cells incubated in medium alone.
Data from multiplex FBI demonstrate that the incuba-
tion of HCF cells with the LPS-only elicited up to 19.43 ±
3.99-fold higher levels of IL-6 (P < 0.01), 30.25 ± 5.58-fold
IL-8 (P < 0.001), 2.14 ± 0.53-fold IL-1β (P > 0.05) and
2.09 ± 0.56-fold TNFα (P > 0.05) compared to cells incu-
bated in medium alone (Figure 7A). Incubation of HCF
cells with the Poly I:C elicited up to 18.03 ± 2.79-fold
higher levels of IL-6 (P < 0.01), 36.32 ± 4.89-fold IL-8
(P < 0.01), 1.74 ± 0.38-fold IL-1β (P > 0.05) and 1.4 ± 0.39-
fold TNFα (P > 0.05) compared to cells incubated in













































































LPS Stimulation-Cytokine mRNA Expression in HCE Cells
LPS Stimulation-Cytokine Protein Secretion in HCE CellsA
B
Figure 5 HCE cells response to LPS and LPS complex (LPS combined with CD14 and LBP) induction. The protein content of pro-inflammatory
cytokines was measured using cytometric bead array (A). Cytokine-specific mRNA content was measured using real-time PCR (B). The data shown are
representative of triplicate experiments. All values are expressed as mean ± SD. The asterisk (p < 0.05), double asterisk (p < 0.01) and three asterisks
(p < 0.001) represent statistical significance for experiments as compare to cells incubated in medium alone. LPS: Lipopolysaccharide, LBP:
Lipopolysaccharide binding protein, CD14: Cluster of differentiation.
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tent of neither IL-1β nor TNF-α following LPS or poly I:C
stimulation (Figures 7A and 6B).
Cytokines mRNA expression in response to activation HCF
cells with LPS and poly I:C
We found that stimulation of HCF cells using poly I:C
elicited up to 11.45 ± 3.75 fold increase (P < 0.05) in IL-6
mRNA and 27.13 ± 6.97 fold increase in IL-8 mRNA
levels (P < 0.05) as compared with to cells incubated in
medium alone (Figure 6B).
Incubation of HCF cells with LPS elicited IL-6 mRNA
up to 9.56 ± 2.56 fold higher (P < 0.01) and IL-8 mRNA
levels to 18.19 ± 5.44 fold higher of (P < 0.001) compared
to cells incubated in medium alone (Figure 7B).
Similar to the protein content results, the mRNA ex-
pression of neither IL-1β nor TNF-α were significantly el-
evated following LPS or poly I:C stimulation (Figures 7B
and 6B).
IκBα mRNA expression in response to activation HCE
and HCF cells with LPS and poly I:C
The HCE cells stimulation with either LPS complex
or Poly I:C elicited a significant elevation of IκBα
mRNA expression levels to 3.49 ± 0.46 fold (P < 0.05,Figure 5B) and 24.32 ± 2.8 fold (P < 0.001, Figure 6A)
respectively.
Incubation of HCF cells with either LPS complex or
Poly I:C elicited a significant elevation of IκBα mRNA
expression levels to 13.11 ± 5.04 fold (P < 0.01, Figure 7B)
and 25.56 ± 8.18 fold (P < 0.01, Figure 6B) respectively.
Discussion
In this study we brought evidence that HCE and HCF
cells constitutively express mRNA specific for TLR2-4,
TLR7 and TLR9 as well as TLR3- and TLR4- proteins
on the cell surface. Our results suggest that these cells
are capable of responding to TLR stimulation, culminat-
ing in the secretion of several pro-inflammatory media-
tors that are known to be down-stream effectors of the
TLR pathway, along with up-regulation of their respect-
ive genes.
Our results show that while stimulation of HCE cells
with LPS culminated in increased mRNA contents of
both TLR3 and TLR4, HCE cells’ activation with poly I:C
elicited increase mRNA levels of TLR3 only. This appar-
ent inconsistency might be explained by a possible differ-
ence in the kinetics and half-lives of the different RNAs.
A real-time PCR analysis conducted over a longer time-
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Figure 6 HCE and HCF cells following activation with poly I:C and LPS respectively. A. HCE cells response to poly I:C stimulation. HCE cells
were incubated with poly I:C. The protein content of pro-inflammatory cytokines was measured using cytometric bead array technique (A). The
cytokine-specific mRNA content was measured using real-time PCR (B). The data shown are representative of triplicate experiments. All values are
expressed as mean ± SD. The asterisk (p < 0.05), double asterisk (p < 0.01) and three asterisks (p < 0.001) represent statistical significance for
experiments as compare to cells incubated in medium alone. B. HCF cells response to LPS stimulation. The protein content of pro-inflammatory
cytokines was measured using cytometric bead array technique (Figure 7A). Cytokine-specific mRNA content was measured using real-time PCR.
The data shown are representative of triplicate experiments (Figure 7B). All values are expressed as mean ± SD. The asterisk (p < 0.05) and the
double asterisk (p < 0.01) represent statistical significance for experiments as compare to medium.
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poly I:C and LPS, while stimulating secretion of pro-
inflammatory cytokines and the up-regulation of their
respective genes, was found to decrease TLRs surface ex-
pression, as measured using flow cytometry. LPS-induced
TLR4 suppression is an established concept. It has been
described since the 1940s, that low doses of LPS can
suppress the immune response to endotoxin challenge, a
phenomenon termed LPS hyporesponsiveness or LPS tol-
erance [17-19]. The discovery of the Toll-like receptor
family set a new interest in this phenomenon, and severalmechanisms have been proposed to explain it, among
them a decrease in surface expression of TLR4. The LPS
tolerance might lead to better outcomes in patients with
septic shock, perhaps by inhibiting the detrimental effects
in an unchecked inflammatory process [20-22] Tolerance
induction following TLR activation was previously ob-
served in the human cornea. Kumar et al. observed that
pre-exposure of HCE cells to low-dose flagellin, the ligand
of TLR5, induced a state of tolerance, characterized by






























































LPS Stimulation-Cytokine Protein Secretion








Figure 7 HCF cells response to poly I:C stimulation. HCF cells were incubated with poly I:C (5 μg/ml). The protein content of pro-inflammatory
cytokines was measured using cytometric bead array technique (A). The cytokine-specific mRNA content was measured using real-time PCR (B). The
data shown are representative of triplicate experiments. All values are expressed as mean ± SD. The double asterisk (p < 0.01) and three asterisks
(p < 0.001) represent statistical significance for experiments as compare to medium.
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surface expression in HCE cells following ligand activa-
tion is a generalization of the LPS tolerance described in
the previous paragraph, and constitutes a negative-feedback
loop that is important in containing the immune response,
and might play a role in forming an immune-silent envir-
onment in the human cornea.
We observed that stimulation of TLR3 and TLR4 was
followed by an increase in the content of TLR-specific
mRNA. Interestingly, in apparent dissociation, the recep-
tors’ protein content was noted to decrease. Our present
findings are in accordance with a previous work on TLR4
expression in patients with sepsis, that revealed early
TLR4-protein down-regulation, using flow cytometry.
Skinner et al. postulated that these patients may at first re-
spond with TLR4 activation and up-regulation, as shown
by cytokine secretion profile, thereby over-expressing the
pro-inflammatory cytokines that are characteristic of sep-
sis [24]. A subsequent TLR4 down-regulation could reflect
a possible negative feedback mechanism, important for
mitigating the inflammatory process. We postulate that a
similar mechanism is found in HCE cells of the human
eye. It is reasonable to assume, that while inappropriate
secretion of pro-inflammatory cytokines is at best to beavoided and thus silenced, upon stimulation of TLR3 and
TLR4, a preparatory phase, involving enhanced transcrip-
tion of TLR3 and TLR4-specific genes, is beneficent. We
must stress, nonetheless, that this last proposition is a
mere hypothesis that has to be investigated in a further
work.
Stimulation of TLR3 and TLR4 in HCF did not elicit a
statistically significant decrease in surface expression, as
was noted in HCE cells. It is interesting to note, that unlike
HCE cells that responded with profound secretion of pro-
inflammatory cytokines following TLR activation, HCF se-
creted only IL-6 and IL-8. These findings might reflect a
distinct behavior of HCF, which may be more resistant to
TLR stimulation, and less prone to initiate a profound in-
flammatory response.
Conclusions
This work brought the first evidence for the expression
of functional TLR3 and TLR4 receptors on human con-
junctiva fibroblasts (HCF), capable of responding to
TLR-specific ligands, and initiating an immune response
by up-regulating pro-inflammatory genes and secreting
various cytokines and inflammatory mediators. The data
shown in this work may support the existence in the
Erdinest et al. Journal of Inflammation 2014, 11:3 Page 10 of 10
http://www.journal-inflammation.com/content/11/1/3human cornea of the long-described LPS tolerance, and
could reflect a protective mechanism against the inflam-
matory response. Along with the description of flagellin-
induced TLR5 inhibition in the cornea, our data of
TLR3 and TLR4 suppression by poly I:C and LPS could
reflect a broader behavior of the TLR family in response
to ligand stimulation, and help elucidate the nature of
TLR-associated diseases. The HCF cells, important con-
tributors to several ocular pathologies, were, as far as
our research of the literature, devoid of a systematic
characterization of the TLR family. This work has shown
the gene and protein expression of several TLRs in HCF,
and brought evidence to their functionality. Further re-
search will help unraveling role of TLRs in conjunctival
diseases.
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